logo

For the Inventor, By the Inventor

Lyons, France

Olivier Breyne

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 2.6

ph-index = 9

Forward Citations = 197(Granted Patents)


Location History:

  • Borneil-sur-marne, FR (2002)
  • Lyons, FR (2001 - 2018)

Company Filing History:

goldMedal8 out of 28 
 
Corning S.a.
 patents
silverMedal7 out of 50 
 
Flamel Technologies
 patents
bronzeMedal4 out of 7,273 
 
Corning Incorporated
 patents
4. 1 out of 55 
 
Flamel Ireland Limited
 patents
5. 1 out of 1 
 
Corning Sas
 patent
6. 1 out of 832,843 
Other
 patents

Years Active: 2001-2018

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents
1. 10052289 - Composition comprising an active agent with low aqueous solubility (2018-08-21),
2. 8716217 - Polyglutamic acids functionalized by cationic groups and hydrophobic groups and applications thereof, in particular therapeutic applications thereof (2014-05-06),
3. 8481019 - Modified-release particles of polyelectrolytes and pharmaceutical formulations thereof (2013-07-09),
4. 8293255 - Polyglutamic acids functionalised by histidine derivatives and hydrophobic groups and the uses thereof, in particular for therapeutic purposes (2012-10-23),
5. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),
6. 7919572 - Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications (2011-04-05),
7. 7683024 - Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications (2010-03-23),
8. 7678882 - Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof (2010-03-16),
9. 7659365 - Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications (2010-02-09),
10. 7332260 - Naphthopyrans annelated in C5-C6, their preparation and compositions and (CO)polymer matrices containing them (2008-02-19),
11. 7250120 - Benzo-, naphtho- and phenanthrochromene substituted by carbamated or ureated phenyls, preparation thereof and compositions and articles containing them (2007-07-31),
12. 6719925 - Naphthopyrans with a heterocycle in the 5, 6-position, preparation, and (co)polymer compositions and matrices containing them (2004-04-13),
13. 6558583 - Naphthopyrans annelated in C5-C6 with a dihydrobenzo-cycloheptatriene-type carbocycle and compositions and matrices containing them (2003-05-06),
14. 6506538 - Naphthopyrans annelated in C5-C6, their preparation and compositions and (co)polymer matrices containing them (2003-01-14),
15. 6506322 - Naphthopyrans annelated in C5-C6 with an indene- or dihydronaphthalene-type carbocycle, and compositions and (co)polymer matrices containing them (2003-01-14),

Title: Olivier Breyne: Innovator in Biodegradable Materials and Therapeutic Applications

Introduction

Olivier Breyne, located in Lyons, France, is a prolific inventor with 22 patents to his name. His work primarily focuses on compositions enhancing the solubilization of active ingredients, particularly in the pharmaceutical and cosmetic fields. Breyne's innovations have significantly impacted the development of biodegradable materials that facilitate the effective delivery of active principles.

Latest Patents

Among Olivier Breyne's latest patents is a composition that comprises an active agent with low aqueous solubility. This invention emphasizes the association of the active ingredient with nanoparticles formed by a specific POM polymer. By achieving a minimum concentration of 5 μmol/g of POM, this invention seeks to improve the aqueous solubilization of low solubility active agents.

Another noteworthy patent involves polyglutamic acids that are functionalized by cationic and hydrophobic groups. This innovation outlines novel biodegradable materials based on modified polyamino acids, which are especially beneficial for the delivery of active principles. The patented method allows for the creation of polymeric materials that meet essential criteria such as biocompatibility, biodegradability, and effective association and release of active principles in vivo.

Career Highlights

Breyne has worked with recognized companies such as Corning S.A. and Flamel Technologies, where he has contributed his expertise in developing innovative solutions in pharmaceuticals and biologically active materials. His work at these companies has played a crucial role in advancing technologies related to drug delivery and active principle vectorization.

Collaborations

Throughout his career, Olivier Breyne has collaborated with distinguished colleagues, including You-Ping Chan and Patrick Jean. These collaborations have fostered a dynamic exchange of ideas, leading to groundbreaking advancements in the field of biodegradable materials and therapeutic applications.

Conclusion

Olivier Breyne stands out as a leading inventor in the realm of biodegradable materials and therapeutic innovations. With a significant portfolio of patents reflecting his dedication to enhancing active ingredient solubilization and vectorization, Breyne continues to contribute profoundly to the fields of pharmaceuticals and biotechnology. His work not only exemplifies the potential of innovative thinking but also holds promise for future advancements in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…